Business
Pfizer, BioNTech warn UK against plans to delay second vaccine jab – Sydney Morning Herald
Health authorities across the world are debating the wisdom of delaying the second shot for three months to make scarce supplies go further.
Many experts have supported the decision to delay the second jab so that more people can get the first given the gravity of the UK’s rapidly worsening second wave. But others such as US infectious diseases chief Anthony Fauci have criticised the dosing regime because it was not tested in clinical trials.
In a joint statement released on Monday, Germany drug company BioNTech and its American partner Pfizer said there was “no data” to demonstrate that the protection offered by the first dose would…
-
General21 hours agoFootballers and movie stars: PM’s Shanghai tourism push
-
Business20 hours agoNvidia reaches the $4 trillion mark. Can it hit $5 trillion in 2025?
-
Business20 hours agoThis artificial intelligence (AI) and “Magnificent Seven” stock will be the next company to surpass a $3 trillion market cap by the end of 2025
-
Noosa News20 hours agoYIMBYs vs NIMBYs as the battle for affordable housing moves into your backyard